Nadège Vimond

2.4k citations
19 papers · 2k · 1 hit paper · h-index 15

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

    • T-cell and B-cell Immunology 6
    • Cancer Immunotherapy and Biomarkers 2
    • Cancer Cells and Metastasis 1

Nadège Vimond

19 papers receiving 1.9k citations

Nadège Vimond's Hit Papers

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC 2015 · 690 citations
6900+3+7Years since publication200400600

Peers

Nadège Vimond
Comparison fields: 5 of 75
  • Oncology 516
  • Immunology 324
  • Cancer Research 210
  • Molecular Biology 748
  • Hepatology 99
Replace Badreddin Edris with:
Badreddin Edris United States
Gwangil Kim South Korea
Bengt Phung Sweden
Marcel Bundi Switzerland
Andrew E. Cornish United States
Lindsey E. Jones United States
Shamik Mitra Sweden
Mathilde Skaarup Larsen Denmark
Koji Shindo Japan
Phuong H. Dao United States
Nadège Vimond relative to Badreddin Edris United States Badreddin Edris's profile →
Citations per field
00.5×2×4×5.8×
Badreddin Edris · 1×
Citations per year

Countries citing papers authored by Nadège Vimond

Since Specialization
Citations

This map shows the geographic impact of Nadège Vimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Vimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Vimond more than expected).

Fields of papers citing papers by Nadège Vimond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Vimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Vimond. The network helps show where Nadège Vimond may publish in the future.

Co-authors

The 25 scholars most cited alongside Nadège Vimond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nadège Vimond Line = papers co-authored together Nadège Vimond links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Hit paper breakdown →
2015690
2 2011348
3 2013260
4 2015143
5 2012123
6 201964
7 201662
8 201148
9 200843
10 201140
11 202024
12 201922
13 201621
14 202216
15 202015
16 202013
17 202212
18 202210
19 20261

About Nadège Vimond

Nadège Vimond is a scholar working on Immunology, Oncology, Molecular Biology, Gastroenterology and Hepatology, having authored 19 papers that have together received 2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Gastrointestinal Tumor Research and Treatment (1 paper), Multiple Sclerosis Research Studies (1 paper), Cancer Cells and Metastasis (1 paper), Extracellular vesicles in disease (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (516 citations), Immunology (324 citations), Cancer Research (210 citations), Molecular Biology (748 citations) and Hepatology (99 citations). Nadège Vimond has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Françoise Farace, Nathalie Jacques, Agnès Laplanche, Philippe R. Vielh, Fanny Billiot, Karim S. Fizazi, Sylvestre Le Moulec, Ludovic Lacroix, Christophe Massard and Fabrice André. Their work appears in journals such as Journal of Clinical Investigation, British Journal of Cancer, Frontiers in Immunology, Blood Advances and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact